97 related articles for article (PubMed ID: 34944844)
21. Multi-Marker Immunofluorescent Staining and PD-L1 Detection on Circulating Tumour Cells from Ovarian Cancer Patients.
Asante DB; Morici M; Mohan GRKA; Acheampong E; Spencer I; Lin W; van Miert P; Gibson S; Beasley AB; Ziman M; Calapre L; Meniawy TM; Gray ES
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944844
[TBL] [Abstract][Full Text] [Related]
22. Powering single-cell genomics to unravel circulating tumour cell subpopulations in non-small cell lung cancer patients.
Acheampong E; Morici M; Abed A; Bowyer S; Asante DB; Lin W; Millward M; Gray ES; Beasley AB
J Cancer Res Clin Oncol; 2023 May; 149(5):1941-1950. PubMed ID: 35896898
[TBL] [Abstract][Full Text] [Related]
23. PD-L1 Expression with Epithelial Mesenchymal Transition of Circulating Tumor Cells Is Associated with Poor Survival in Curatively Resected Non-Small Cell Lung Cancer.
Manjunath Y; Upparahalli SV; Avella DM; Deroche CB; Kimchi ET; Staveley-O'Carroll KF; Smith CJ; Li G; Kaifi JT
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31212653
[TBL] [Abstract][Full Text] [Related]
24. Diversity of Epithelial-Mesenchymal Phenotypes in Circulating Tumour Cells from Prostate Cancer Patient-Derived Xenograft Models.
Hassan S; Blick T; Thompson EW; Williams ED
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34206049
[TBL] [Abstract][Full Text] [Related]
25. Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients.
Anantharaman A; Friedlander T; Lu D; Krupa R; Premasekharan G; Hough J; Edwards M; Paz R; Lindquist K; Graf R; Jendrisak A; Louw J; Dugan L; Baird S; Wang Y; Dittamore R; Paris PL
BMC Cancer; 2016 Sep; 16(1):744. PubMed ID: 27658492
[TBL] [Abstract][Full Text] [Related]
26. Genetic analysis of heterogeneous subsets of circulating tumour cells from high grade serous ovarian carcinoma patients.
Asante DB; Mohan GRKA; Acheampong E; Ziman M; Calapre L; Meniawy TM; Gray ES; Beasley AB
Sci Rep; 2023 Feb; 13(1):2552. PubMed ID: 36781954
[TBL] [Abstract][Full Text] [Related]
27. The Detection of Stem-Like Circulating Tumor Cells Could Increase the Clinical Applicability of Liquid Biopsy in Ovarian Cancer.
Gening SO; Abakumova TV; Gafurbaeva DU; Rizvanov AA; Antoneeva II; Miftakhova RR; Peskov AB; Gening TP
Life (Basel); 2021 Aug; 11(8):. PubMed ID: 34440558
[TBL] [Abstract][Full Text] [Related]
28. An Automatic Platform Based on Nanostructured Microfluidic Chip for Isolating and Identification of Circulating Tumor Cells.
Jou HJ; Chou LY; Chang WC; Ho HC; Zhang WT; Ling PY; Tsai KH; Chen SH; Chen TH; Lo PH; Chen M; Hsu HT
Micromachines (Basel); 2021 Apr; 12(5):. PubMed ID: 33919456
[TBL] [Abstract][Full Text] [Related]
29. Development and validation for prognostic nomogram of epithelial ovarian cancer recurrence based on circulating tumor cells and epithelial-mesenchymal transition.
Yang J; Ma J; Jin Y; Cheng S; Huang S; Zhang N; Wang Y
Sci Rep; 2021 Mar; 11(1):6540. PubMed ID: 33753862
[TBL] [Abstract][Full Text] [Related]
30. Ovarian cancer: new strategies and emerging targets for the treatment of patients with advanced disease.
Arend RC; Jackson-Fisher A; Jacobs IA; Chou J; Monk BJ
Cancer Biol Ther; 2021 Feb; 22(2):89-105. PubMed ID: 33427569
[TBL] [Abstract][Full Text] [Related]
31. Unraveling the Mysteries of PAX8 in Reproductive Tract Cancers.
Chaves-Moreira D; Morin PJ; Drapkin R
Cancer Res; 2021 Feb; 81(4):806-810. PubMed ID: 33361393
[TBL] [Abstract][Full Text] [Related]
32. Clinical Application of Circulating Tumor Cells and Circulating Tumor DNA in Uveal Melanoma.
Beasley A; Isaacs T; Khattak MA; Freeman JB; Allcock R; Chen FK; Pereira MR; Yau K; Bentel J; Vermeulen T; Calapre L; Millward M; Ziman MR; Gray ES
JCO Precis Oncol; 2018; 2():. PubMed ID: 32913999
[TBL] [Abstract][Full Text] [Related]
33. Analysis of a Real-World Cohort of Metastatic Breast Cancer Patients Shows Circulating Tumor Cell Clusters (CTC-clusters) as Predictors of Patient Outcomes.
Costa C; Muinelo-Romay L; Cebey-López V; Pereira-Veiga T; Martínez-Pena I; Abreu M; Abalo A; Lago-Lestón RM; Abuín C; Palacios P; Cueva J; Piñeiro R; López-López R
Cancers (Basel); 2020 Apr; 12(5):. PubMed ID: 32365530
[TBL] [Abstract][Full Text] [Related]
34. PD-L1 Expression on Circulating Tumor Cells May Be Predictive of Response to Pembrolizumab in Advanced Melanoma: Results from a Pilot Study.
Khattak MA; Reid A; Freeman J; Pereira M; McEvoy A; Lo J; Frank MH; Meniawy T; Didan A; Spencer I; Amanuel B; Millward M; Ziman M; Gray E
Oncologist; 2020 Mar; 25(3):e520-e527. PubMed ID: 32162809
[TBL] [Abstract][Full Text] [Related]
35. Pre-Analytical and Analytical Variables of Label-Independent Enrichment and Automated Detection of Circulating Tumor Cells in Cancer Patients.
Koch C; Joosse SA; Schneegans S; Wilken OJW; Janning M; Loreth D; Müller V; Prieske K; Banys-Paluchowski M; Horst LJ; Loges S; Peine S; Wikman H; Gorges TM; Pantel K
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32069934
[TBL] [Abstract][Full Text] [Related]
36. Cancer transcriptomic profiling from rapidly enriched circulating tumor cells.
Morrison GJ; Cunha AT; Jojo N; Xu Y; Xu Y; Kwok E; Robinson P; Dorff T; Quinn D; Carpten J; Manojlovic Z; Goldkorn A
Int J Cancer; 2020 May; 146(10):2845-2854. PubMed ID: 32037533
[TBL] [Abstract][Full Text] [Related]
37. Detection and prognostic role of heterogeneous populations of melanoma circulating tumour cells.
Aya-Bonilla CA; Morici M; Hong X; McEvoy AC; Sullivan RJ; Freeman J; Calapre L; Khattak MA; Meniawy T; Millward M; Ziman M; Gray ES
Br J Cancer; 2020 Mar; 122(7):1059-1067. PubMed ID: 32037400
[TBL] [Abstract][Full Text] [Related]
38. A New Era in Liquid Biopsy: From Genotype to Phenotype.
Kelley SO; Pantel K
Clin Chem; 2020 Jan; 66(1):89-96. PubMed ID: 31811003
[TBL] [Abstract][Full Text] [Related]
39. PD-L1
Zhang L; Zhang X; Liu Y; Zhang T; Wang Z; Gu M; Li Y; Wang DD; Li W; Lin PP
Cancer Lett; 2020 Jan; 469():355-366. PubMed ID: 31678168
[TBL] [Abstract][Full Text] [Related]
40. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES
Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
